Publicaciones en colaboración con investigadores/as de Università di Camerino (7)

2023

  1. Administration of Linoleoylethanolamide Reduced Weight Gain, Dyslipidemia, and Inflammation Associated with High-Fat-Diet-Induced Obesity

    Nutrients, Vol. 15, Núm. 20

2021

  1. Palmitoleoylethanolamide is an efficient anti-obesity endogenous compound: Comparison with oleylethanolamide in diet-induced obesity

    Nutrients, Vol. 13, Núm. 8

2018

  1. PPARα/CB1 receptor dual ligands as a novel therapy for alcohol use disorder: Evaluation of a novel oleic acid conjugate in preclinical rat models

    Biochemical Pharmacology, Vol. 157, pp. 235-243

2016

  1. Role of the satiety factor oleoylethanolamide in alcoholism

    Addiction Biology, Vol. 21, Núm. 4, pp. 859-872

2011

  1. Endocannabinoid regulation of acute and protracted nicotine withdrawal: Effect of FAAH inhibition

    PLoS ONE, Vol. 6, Núm. 11

2007

  1. The anandamide transport inhibitor AM404 reduces ethanol self-administration

    European Journal of Neuroscience, Vol. 26, Núm. 2, pp. 476-486

2005

  1. Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats

    European Journal of Neuroscience, Vol. 21, Núm. 8, pp. 2243-2251